Viseven is a Ukrainian company that has grown into a global player in digital pharma. Its client portfolio includes over 20 leading international pharmaceutical companies.
Viseven specializes in digital communications for the pharmaceutical and healthcare sectors. Its mission is to help pharma brands build effective digital engagement with doctors, patients, and other stakeholders — all while complying with strict industry regulations.
The company’s flagship product is eWizard — a platform for creating, adapting, and publishing multimedia content within omnichannel strategies. It enables users to develop, edit, and deploy marketing materials (such as presentations, eDetailing, email campaigns, videos, and more) in full compliance with medical regulations (like FDA and EMA). One of its key advantages is the ability to quickly adapt a single piece of content across different channels and markets — without duplicating work.
Viseven was among the first in the industry to introduce a modular content approach for pharma. This allows content to be assembled like LEGO blocks for different audiences, languages, and regions — significantly reducing localization time and costs.
Viseven collaborates with global pharma corporations and operates offices across Europe, North and South America, and Asia. The company actively implements AI-driven solutions in pharma marketing and is considered one of the technological leaders in the digital pharma space.
There’s no room for improvisation in artillery. Only clear processes, proven solutions, and precise calculations get the job done. Business operates by the same principles: efficiency, planning, and measurable results. That’s the foundation on which we connect with companies that value structure, analytics, and actions that deliver real impact. We’re grateful for the productive partnership!
Write to us if you have ideas or need something. You can also leave your email, and we will notify you about our news
Your message has just appeared in my "Inbox" folder.
Let's talk later!
We will notify you about our news